ArticleOncoimmunology2020

Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.

Mei Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.